Personal information

Activities

Employment (2)

The University of Texas M D Anderson Cancer Center: Houston, Texas, US

2020-10-04 to present | Instructor, RFA (Experiemntal Therapeutics)
Employment
Source: Self-asserted source
Paola Amero

University of Texas M D Anderson Cancer Center: Houston, TX, US

2015-11-04 to 2017-12-13 | Postdoctoral Fellow (Experimental Therapeutics)
Employment
Source: Self-asserted source
Paola Amero

Education and qualifications (2)

University of Texas MD Anderson Cancer Center: Houston, TX, US

2020-10-01 to present | Instructor, RFA (Experiemntal Therapeutics)
Qualification
Source: Self-asserted source
Paola Amero

University of Naples “ Federico II”: Naples, Campania, IT

2009-11-13 to 2013-04-23 | PhD (Department of Pharmacology)
Education
Source: Self-asserted source
Paola Amero

Works (15)

Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside

Cancers
2024-08 | Journal article | Author
Contributors: Elif Çakan; Olivia Lara; Anna Szymanowska; Emine Bayraktar; Arturo Chavez-Reyes; Gabriel Lopez-Berestein; Paola Amero; CRISTIAN RODRIGUEZ-AGUAYO
Source: check_circle
Multidisciplinary Digital Publishing Institute

EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer

International Journal of Molecular Sciences
2024-01 | Journal article | Author
Contributors: Robiya Joseph; Santosh K. Dasari; Sujanitha Umamaheswaran; Lingegowda S. Mangala; Emine Bayraktar; CRISTIAN RODRIGUEZ-AGUAYO; Yutuan Wu; Nghi Nguyen; Reid T. Powell; Mary Sobieski et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer

Non-Coding RNA
2023-11 | Journal article | Author
Contributors: Moisés Martínez-Castillo; Abdelrahman M. Elsayed; Gabriel López-Berestein; Paola Amero; CRISTIAN RODRIGUEZ-AGUAYO
Source: check_circle
Multidisciplinary Digital Publishing Institute

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges

Cancers
2023-11 | Journal article | Author
Contributors: Wojciech Szymanowski; Anna Szymanowska; Anna Bielawska; Gabriel Lopez-Berestein; CRISTIAN RODRIGUEZ-AGUAYO; Paola Amero
Source: check_circle
Multidisciplinary Digital Publishing Institute

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment

Non-Coding RNA
2023-08 | Journal article | Author
Contributors: Anna Szymanowska; CRISTIAN RODRIGUEZ-AGUAYO; Gabriel Lopez-Berestein; Paola Amero
Source: check_circle
Multidisciplinary Digital Publishing Institute

Aptamers as Insights for Targeting SARS-CoV-2

Biologics
2023-05 | Journal article | Author
Contributors: Suna Karadeniz Saygılı; Anna Szymanowska; Gabriel Lopez-Berestein; CRISTIAN RODRIGUEZ-AGUAYO; Paola Amero
Source: check_circle
Multidisciplinary Digital Publishing Institute

microRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development

Non-Coding RNA
2023-04 | Journal article | Author
Contributors: Emine Bayraktar; Recep Bayraktar; Hulya Oztatlici; Gabriel Lopez-Berestein; Paola Amero; CRISTIAN RODRIGUEZ-AGUAYO
Source: check_circle
Multidisciplinary Digital Publishing Institute

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer

International Journal of Molecular Sciences
2023-02 | Journal article | Author
Contributors: Santosh K. Dasari; Robiya Joseph; Sujanitha Umamaheswaran; Lingegowda S. Mangala; Emine Bayraktar; CRISTIAN RODRIGUEZ-AGUAYO; Yutuan Wu; Nghi Nguyen; Reid T. Powell; Mary Sobieski et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer

Cancers
2021-07 | Journal article | Author
Contributors: Debaditya Chakraborty; Cristina Ivan; Paola Amero; Maliha Khan; CRISTIAN RODRIGUEZ-AGUAYO; Hakan Başağaoğlu; Gabriel Lopez-Berestein
Source: check_circle
Multidisciplinary Digital Publishing Institute

Inactivating Mutations of the <i>IK</i> Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy

Cancers
2021-05 | Journal article | Author
Contributors: Chao Gao; Guangxu Jin; Elizabeth Forbes; Lingegowda S. Mangala; Yingmei Wang; CRISTIAN RODRIGUEZ-AGUAYO; Paola Amero; Emine Bayraktar; Ye Yan; Gabriel Lopez-Berestein et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway

International Journal of Molecular Sciences
2021-02 | Journal article | Author
Contributors: Abdelrahman M. Elsayed; Emine Bayraktar; Paola Amero; salama salama; Abdelaziz H. Abdelaziz; Raed Ismail; Xinna Zhang; Cristina Ivan; Anil K. Sood; Gabriel Lopez-Berestein et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology

Cancers
2020-10 | Journal article | Author
Contributors: Paola Amero; soumen khatua; CRISTIAN RODRIGUEZ-AGUAYO; Gabriel Lopez-Berestein
Source: check_circle
Multidisciplinary Digital Publishing Institute

Back to the Future: Rethinking the Great Potential of lncRNA<sub>S</sub> for Optimizing Chemotherapeutic Response in Ovarian Cancer

Cancers
2020-08 | Journal article | Author
Contributors: Abdelrahman M. Elsayed; Paola Amero; salama salama; Abdelaziz H. Abdelaziz; Gabriel Lopez-Berestein; CRISTIAN RODRIGUEZ-AGUAYO
Source: check_circle
Multidisciplinary Digital Publishing Institute

Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer

International Journal of Molecular Sciences
2020-04 | Journal article | Author
Contributors: Yasmin M. Attia; samia shouman; Salama A. Salama; Cristina Ivan; Abdelrahman M. Elsayed; Paola Amero; CRISTIAN RODRIGUEZ-AGUAYO; Gabriel Lopez-Berestein
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immune Modulatory Long-Non-Coding RNA as a Potential Therapeutic Target in Cancer

Source: check_circle
Multidisciplinary Digital Publishing Institute